PAPER Louis ED, Benito-León J
SEARCH RESULTS
331209 RESULTS
PAPER Feuillette S, Miguel L, Frébourg T, Campion D, Lecourtois M
Drosophila models of human tauopathies indicate that Tau protein toxicity in vivo is mediated by soluble cytosolic phosphorylated forms of the protein.
J Neurochem. 2010 May;113(4):895-903. PubMed: 20193038PAPER Tian G, Kong Q, Lai L, Ray-Chaudhury A, Lin CL
Increased expression of cholesterol 24S-hydroxylase results in disruption of glial glutamate transporter EAAT2 association with lipid rafts: a potential role in Alzheimer's disease.
J Neurochem. 2010 May;113(4):978-89. PubMed: 20193040PAPER Zhao QL, Zhou Y, Wang YL, Dong KH, Wang YJ
A new diagnostic algorithm for vascular cognitive impairment: the proposed criteria and evaluation of its reliability and validity.
Chin Med J (Engl). 2010 Feb 5;123(3):311-9. PubMed: 20193251PAPER Cao Y, Ravid R, Guan ZZ
[Changes in expression of synaptic proteins in brains of patients with Alzheimer's disease].
Zhonghua Bing Li Xue Za Zhi. 2009 Dec;38(12):833-4. PubMed: 20193460PAPER Zambón D, Quintana M, Mata P, Alonso R, Benavent J, Cruz-Sánchez F, Gich J, Pocoví M, Civeira F, Capurro S, Bachman D, Sambamurti K, Nicholas J, Pappolla MA
Higher incidence of mild cognitive impairment in familial hypercholesterolemia.
Am J Med. 2010 Mar;123(3):267-74. PubMed: 20193836PAPER Giorgetti M, Gibbons JA, Bernales S, Alfaro IE, Drieu La Rochelle C, Cremers T, Altar CA, Wronski R, Hutter-Paier B, Protter AA
Cognition-enhancing properties of Dimebon in a rat novel object recognition task are unlikely to be associated with acetylcholinesterase inhibition or N-methyl-D-aspartate receptor antagonism.
J Pharmacol Exp Ther. 2010 Jun;333(3):748-57. PubMed: 20194526PAPER Ohe K, Mayeda A
HMGA1a trapping of U1 snRNP at an authentic 5' splice site induces aberrant exon skipping in sporadic Alzheimer's disease.
Mol Cell Biol. 2010 May;30(9):2220-8. PubMed: 20194618PAPER Yuri Jang, Kim G, Chiriboga D
Knowledge of Alzheimer's disease, feelings of shame, and awareness of services among Korean American elders.
J Aging Health. 2010 Jun;22(4):419-33. PubMed: 20194682PAPER Simonyi A, He Y, Sheng W, Sun AY, Wood WG, Weisman GA, Sun GY
Targeting NADPH oxidase and phospholipases A2 in Alzheimer's disease.
Mol Neurobiol. 2010 Jun;41(2-3):73-86. PubMed: 20195796PAPER Lue LF, Kuo YM, Beach T, Walker DG
Microglia activation and anti-inflammatory regulation in Alzheimer's disease.
Mol Neurobiol. 2010 Jun;41(2-3):115-28. PubMed: 20195797PAPER Wolf RC, Uttner I, Osterfeld ND
[Depressive symptoms in a case of "posterior cortical atrophy"].
Fortschr Neurol Psychiatr. 2010 Apr;78(4):226-9. PubMed: 20195949PAPER Iova A, Mihancea P, Sabău M
General aspects of the morbidity in Alzheimer's dementia during 2003-2005 at the Neurology and Psychiatry Clinical Hospital Oradea.
Rev Med Chir Soc Med Nat Iasi. 2009 Oct-Dec;113(4):1089-92. PubMed: 20191879PAPER Boyle PA, Buchman AS, Barnes LL, Bennett DA
Effect of a purpose in life on risk of incident Alzheimer disease and mild cognitive impairment in community-dwelling older persons.
Arch Gen Psychiatry. 2010 Mar;67(3):304-10. PubMed: 20194831SNX1
ANTIBODY kit manufacturer Cat# H00006642-AP21<br /> Produced by Abnova Capture antibody: rabbit MaxPab® affinity purified polyclonal anti-SNX1; Detection antibody: mouse purified polyclonal anti-SNX1 SNX1-sorting nexin 1 Protein Trafficking Novus Biologicals
Current Filters
No filters selected